MedPath

Upper GI Outcomes Following EMR

Completed
Conditions
Adenoma, Villous
Registration Number
NCT02305290
Lead Sponsor
Professor Michael Bourke
Brief Summary

The purpose of this study is to evaluate the long-term outcomes of Endoscopic Resection (ER) of superficial lesions of the Upper Gastrointestinal Tract(UGIT)

Detailed Description

Endoscopic resection (ER) of superficial lesions of the upper gastrointestinal tract is a safe and effective surgery-sparing modality in experienced hands. It is often curative of dysplastic lesions and is associated with minimal complications and high patient acceptance (1-5). Westmead Hospital has accumulated a significant amount of experience in the removal of such lesions; however, there is limited research to document the long term outcomes of patients undergoing endoscopic resection.The purpose of this study is to evaluate the long-term outcomes of ER of superficial lesions of the UGIT.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • UGIT lesion > 10mm
  • Lesion limited to the mucosal and/or submucosal layer (T1 lesion)
  • Aged 18 years or older
Exclusion Criteria
  • Lesion less than 10mm
  • Gastric lesion involves the muscularis propria (T2 lesion) on other staging modalities such as endoscopic ultrasonography (EUS)
  • Aged younger than 18 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Observed procedural data14 days

Number of Participants with Adverse Events as a Measure of Safety and Tolerability Outcomes

Secondary Outcome Measures
NameTimeMethod
Analysis of the costs of this procedure compared to previous treatments14 days

Perform cost-utility analyses comparing different treatment approaches for UGIT lesions

Trial Locations

Locations (1)

Westmead Endoscopy Unit

🇦🇺

Westmead, New South Wales, Australia

Westmead Endoscopy Unit
🇦🇺Westmead, New South Wales, Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.